4
Apr
2019
Blocking epigenetic “Swiss army knife” may be a new strategy for treating colorectal cancer
GRAND RAPIDS, Mich. (April 4, 2019) — A new study out today in Cancer Cell shows that blocking specific regions of a... Read More
9
May
2018
Fighting cancer is a team effort
/
By Dr. Peter A. Jones and Dr. Steve Baylin Co-leaders, Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team
21
Dec
2017
10 highlights: A look back at 2017
With 2017 quickly coming to close, we’d like to reflect on all that’s been accomplished by rounding up some of this year’s... Read More
30
Nov
2017
Clinical trial investigates possible triple threat for lung cancer
/
A first-of-its-kind combination of medications may enable the immune system to better combat lung cancer, which claims more lives than any other... Read More
12
Oct
2017
A Catalyst for combating cancer
/
Nearly $5.5 million in grant funding to fuel collaborative clinical trials in lung and bladder cancers By Dr. Peter Jones and Dr.... Read More
15
May
2017
Dr. Stephen Baylin becomes third VARI-affiliated scientist to be elected to National Academy of Sciences
VARI-affiliated cancer researcher Stephen Baylin, M.D., has been elected to the National Academy of Sciences (NAS). He is the third VARI-affiliated scientist... Read More
15
May
2017
3
Feb
2017
In their own words: The most exciting advances in cancer research
In honor of World Cancer Day on Saturday, we asked our scientists and collaborators a simple question—what do you think is the... Read More
10
Oct
2016
Combinations and collaborations in the fight against cancer: An interview with Dr. Feyruz Rassool and Dr. Stephen Baylin
/
What happens when scientists collaborate rather than compete? In this case, the result is a combination of two drugs that may be... Read More